
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 May 18
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. • Lead the scientific and operational execution of clinical programs focused on Multiple Sclerosis. • Develop, lead, and maintain study protocols, informed consent forms, clinical study reports, and other key study documents. • Mentor and potentially manage Clinical Research Scientists. • Partner with Clinical Operations, Biometrics, Regulatory, Medical Affairs, and Commercial teams to ensure alignment on clinical strategy and execution. • Write and review scientific content of key clinical and regulatory documents. • Review and interpret safety, efficacy, MRI/imaging, biomarker, laboratory, relapse, and disability progression data throughout study conduct. • Collaborate with CROs and vendors to ensure high-quality study execution, enrollment performance, operational excellence, and inspection readiness. • Support the monitoring of patient safety during study conduct and appropriate tracking, escalation, and follow-up of adverse events and protocol deviations. • Represent Clinical Development in high-impact external settings including advisory boards, regulatory meetings, investigator meetings, and scientific congresses.
• Advanced scientific or clinical degree required (PhD, PharmD, MD or equivalent). • 10+ years of progressive experience in clinical research, clinical development, and global late-stage clinical trial management within biotechnology or pharmaceutical industries. • Significant experience supporting or leading Multiple Sclerosis clinical development programs required. • Experience in cell therapy, gene therapy, immunology, autoimmune disease, or related therapeutic areas strongly preferred. • Deep understanding of neuroimmunology, autoimmune disease biology, MS clinical endpoints, biomarkers, imaging, and treatment landscape. • Demonstrated success developing and executing clinical strategies across multiple programs, including late-stage global clinical trials. • Strong knowledge of GCP, ICH guidelines, global regulatory frameworks, regulatory requirements, and clinical trial methodology. • Strong operational acumen with the ability to independently lead complex projects in fast-paced, highly matrixed organizations. • Experience interpreting complex clinical datasets, including safety, efficacy, biomarker, laboratory, and imaging data. • Experience with investigator-initiated and/or collaborative research trials preferred. • Prior management experience strongly preferred. • Excellent verbal, written, presentation, and interpersonal communication skills. • Proven ability to support strong relationships with internal stakeholders, external investigators, KOLs, regulators, and scientific collaborators. • Experience working in fast-paced and evolving biotech environments preferred. • Willingness and flexibility to travel up to 15% for congresses, investigator meetings, advisory boards, and clinical site visits as needed.
• annual bonus • equity • benefits • participation in the Company’s stock plan
Apply Now🕒 May 15
Senior Statistician providing statistical support for clinical trials at ClinChoice, a global CRO. Leading statistical strategy and collaborating with cross-functional teams in a dynamic environment.
🕒 May 15
201 - 500
Senior Clinical Trial Manager overseeing clinical trial operations and monitoring deliverables. Collaborating with CRAs in a remote environment at a mid-sized CRO specializing in dermatology.
🕒 May 15
10,000+ employees
Senior Clinical Research Manager overseeing clinical monitoring and team performance to ensure compliance at BeOne. Leading the CRA team to enhance trial delivery and mentoring junior CRMs.
🕒 May 14
Senior Clinical Trial Manager at Ascendis Pharma overseeing global clinical trials for rare diseases. Working cross-functionally to manage projects and ensure compliance throughout clinical processes.
🇺🇸 United States – Remote
💵 $160k - $170k / year
⏰ Full Time
🟠 Senior
🧪 Clinical Research
🦅 H1B Visa Sponsor
🕒 May 13
Senior Clinical Trial Manager responsible for trial delivery and managing Local Trial Management processes for ICON plc. Collaboration with internal partners and external stakeholders to streamline communication and ensure trial excellence.